कृपया अन्य खोज का प्रयास करें
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. The company’s chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma, and FT522, to treat lymphoma and autoimmune disorders. Its CAR T-cell programs include FT819 to treat hematologic malignancies and solid tumors, and FT825 to treat solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of cancer. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
J. Scott Wolchko | 52 | 2013 | Founder, CEO, President & Director |
John D. Mendlein | 62 | 2007 | Independent Vice Chairman of the Board |
William H. Rastetter | 74 | 2011 | Independent Chairman |
Robert S. Epstein | 67 | 2014 | Independent Director |
Timothy P. Coughlin | 55 | 2013 | Independent Director |
Robert M. Hershberg | 60 | 2020 | Independent Director |
Shefali Agarwal | 48 | 2019 | Independent Director |
Yuan Xu | 53 | 2021 | Independent Director |
Sean J. Morrison | - | 2010 | Member of Scientific Advisory Board |
Lynn Megeney | - | 2010 | Member of Scientific Advisory Board |
Robert S. Langer | 74 | - | Member of Scientific Advisory Board |
Sui Huang | - | 2010 | Member of Scientific Advisory Board |
Stuart Orkin | - | 2010 | Member of Scientific Advisory Board |
Bennett M. Shapiro | 83 | - | Member of Scientific Advisory Board |
Mark Krasnow | - | 2010 | Member of Scientific Advisory Board |
Karin Jooss | 58 | 2019 | Independent Director |
Alberto Hayek | - | 2010 | Member of Scientific Advisory Board |
Steven L. Goldstein | - | 2010 | Member of Scientific Advisory Board |
Michael Stewart Lee | 44 | 2018 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है